Nicotine activates NPY and catecholaminergic neurons in brainstem regions involved in ACTH secretion

Brain Research

Volumn 759, Issue 2, 1997, Pages 259-269

  Matta, Shannon G ^a,b   Valentine, James D ^a,c   Sharp, Burt M ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b HENNEPIN COUNTY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Activin; c Fos; Catecholamine; Galanin; Immunocytochemistry; Nucleus tractus solitarius; Rat

Indexed keywords

NEUROPEPTIDE Y; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CATECHOLAMINE NERVE CELL; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; BRAIN STEM; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; NEUROPEPTIDE Y; NICOTINE; RATS;

EID: 0030836751     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00266-7     Document Type: Article

References (44)

1. Akabayashi A., Zaia C.T., Koenig J.I., Gabriel S.M., Silva I., Liebowitz S.F. Diurnal rhythm of galanin-like immunoreactivity in the paraventricular and suprachiasmatic nuclei and other hypothalamic nuclei. Peptides. 15:1994;1437-1444.
2. Albers H.E., Ottenweller J.E., Liou S.Y., Lumpkin M.D., Anderson E.R. Neuropeptide Y in the hypothalamus: Effect on corticosterone and single-unit activity. Am. J. Physiol. 258:1990;R376-R382.
3. Andersson K., Eneroth P., Agnati L.F. Nicotine-induced increases of noradrenaline turnover in discrete noradrenaline terminal systems of the hypothalamus and median eminence of the rat and their relationship to changes in the secretion of adenohypohyseal hormones. Acta Physiol. Scand. 113:1981;227-231.
4. Andersson K., Siegel R., Fuxe K., Eneroth P. Intravenous injections of nicotine induce very rapid and discrete reductions of hypothalamic catecholamine levels associated with increases of ACTH, vasopressin, and prolactin secretion. Acta Physiol. Scand. 118:1983;35-40.
5. Berkenbosch F., van Oers J., del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 23:1987;524-526.
6. Ceccatelli S., Cortes R., Hokfelt T. Effect of reserpine and colchicine on neuropeptide mRNA levels in the rat hypothalamic paraventricular nucleus. Mol. Brain Res. 9:1991;57-69.
7. Dumont Y., Martel J.-C., Fournier A., St Pierre S., Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol. 38:1992;125-167.
8. Everitt B.J., Hokfelt T., Terenius L., Tatemoto K., Mutt V., Goldstein M. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience. 11:1984;443-462.
9. Fu, Y., Matta, S.G., Valentine, J.D. and Sharp, B.M., ACTH response and nicotine-induced norepinephrine secretion in the rat paraventricular nucleus are mediated through brainstem receptors, Endocrinology (in press).
10. Fuxe K., Andersson K., Eneroth P., Siegel R.A., Agnati L.F. Immobilization stress-induced changes in discrete hypothalamic catecholamine levels and turnover, their modulation by nicotine and relationship to neuroendocrine function. Acta Physiol. Scand. 117:1983;421-426.
11. Haas D.A., George S.R. Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions. Life Sci. 41:1987;2725-2731.
12. Haas D.A., George S.R. Neuropeptide Y-induced effects on hypothalamic corticotropin-releasing factor content and release are dependent on noradrenergic/adrenergic neurotransmission. Brain Res. 498:1989;333-338.
13. Harfstrand A., Eneroth P., Agnati L., Fuxe K. Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines. Regul. Pept. 17:1987;167-179.
14. Inoue T., Inui A., Okita M., Sakatani N., Oya M., Morioka H., Mizuno N., Oimomi M., Baba S. Effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog. Life Sci. 44:1989;1043-1051.
15. Kalia M., Fuxe K., Goldstein M. Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers and terminal processes J. Comp. Neurol. 233:1985;308-332.
16. Kalia M., Fuxe K., Goldstein M. Rat medulla oblongata. III. Adrenergic (C1 and C2) neurons, nerve fibers, and presumptive terminal processes J. Comp. Neurol. 233:1985;333-349.
17. Kalra S.P., Kalra P.S. Neuropeptide Y: a novel peptidergic signal for the control of feeding behavior. Curr. Top. Neuroendocrinol. 10:1990;191-221.
18. Leibowitz S.F. Brain neuropeptide Y: an integrator of endocrine, metabolic and behavioral processes. Brain Res. Bull. 27:1991;333-337.
19. Leibowitz S.F., Sladek C., Spencer L., Tempel D. Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res. Bull. 21:1988;905-912.
20. Leslie R.A. Neuroactive substances in the dorsal vagal complex of the medulla oblongota: nucleus of the tractus solitarius, area postrema, and dorsal motor nucleus of the vagus. Neurochem. Int. 7:1985;191-211.
21. Levin M.C., Sawchenko P.E., Howe P.R.C., Bloom S.R., Polak J.M. Organization of galanin-immunoreactive inputs to the paraventricular nucleus with special reference to their relationship to catecholaminergic afferents. J. Comp. Neurobiol. 261:1987;562-582.
22. Liposits Z., Sievers L., Paull W.K. Neuropeptide Y and ACTH-immunoreactive innervation of corticotropin-releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. An immunocytochemical analysis at the light and electron microscopic level. Histochemistry. 88:1988;227-234.
23. Malendowicz L.K., Nussdorfer G.G., Nowak K.W., Mazzochi G. The possible involvement of galanin in the modulation of the function of the rat pituitary-adrenocortical axis under basal and stressful conditions. Endocr. Res. 20:1994;307-317.
24. Matta S.G., Beyer H.S., McAllen K.M., Sharp B.M. Nicotine elevates rat plasma ACTH by a central mechanism. J. Pharmacol. Exp. Ther. 243:1987;217-226.
25. Matta S.G., McAllen K.M., Sharp B.M. Role of the fourth cerebroventricle in mediating rat plasma ACTH responses to intravenous nicotine. J. Pharmacol. Exp. Ther. 252:1990;623-630.
26. Matta S.G., Singh J., Sharp B.M. Catecholamines mediate nicotine-induced adrenocorticotropin secretion via α-adrenergic receptors. Endocrinology. 127:1990;1646-1655.
27. Matta S.G., Foster C.A., Sharp B.M. Nicotine stimulates the expression of cFos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. Endocrinology. 132:1993;2149-2156.
28. Matta S.G., Foster C.A., Sharp B.M. Selective administration of nicotine into catecholaminergic regions of rat brainstem stimulates adrenocorticotropin secretion. Endocrinology. 133:1993;2935-2942.
29. Matta S.G., McCoy J.G., Foster C.A., Sharp B.M. Nicotinic agonists administered into the fourth ventricle stimulate norepinephrine secretion in the hypothalamic paraventricular nucleus: an in vivo microdialysis study. Neuroendocrinology. 61:1995;383-392.
30. Palkovitz M. Distribution of neuropeptides in the central nervous system: a review of biochemical mapping studies. Prog. Neurobiol. 23:1984;151-189.
31. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, New York, 1986.
32. Plotsky P.M. Pathways to the secretion of adrenocorticotropin: a view from the portal. J. Neuroendocrinol. 3:1991;1-9.
33. Plotsky P.M., Kjaer A., Sutton S.W., Sawchenkom P.E., Vale W. Central activin administration modulates corticotropin-releasing hormone and adrenocorticotropin secretion. Endocrinology. 128:1991;2520-2525.
34. Sawchenko, P.E., Neuropeptides, the paraventricular nucleus, and the integration of hypothalamic neuroendocrine and autonomic function. In Y. Tache, J.E. Morley and M.R. Brown (Eds.), Neuropeptides and Stress, Springer-Verlag, New York, 1989, pp. 73-92.
35. Sawchenko P.E., Swanson L.W., Grzanna R., Howe P.R.C., Bloom S.R., Polak J.M. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular and supraoptic nuclei in the rat. J. Comp. Neurol. 241:1985;138-153.
36. Sawchenko P.E., Plotsky P.M., Pfeiffer S.W., Cunningham E.T., Vaughan J., Rivier J., Vale W. Inhibin β in central neural pathways involved in the control of oxytocin secretion. Nature. 334:1988;615-617.
37. Sharp B.M., Beyer H.S. Rapid desensitization of the acute stimulatory effects of nicotine on rat plasma adrenocorticotropin and prolactin. J. Pharmacol. Exp. Ther. 238:1986;486-491.
38. Swanson L.W., Sawchenko P.E., Berol B., Hartman B.K., Helle K.B., Van Orden D.E. An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus. J. Comp. Neurol. 196:1981;271-285.
39. Swanson L.W., Sawchenko P.E., Lind R.W. Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response. Prog. Brain Res. 68:1986;169-190.
40. Tatemoto K., Carlquist M., Mutt V. Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 296:1982;659-5660.
41. Tsagarakis S., Rees L.H., Besser G.M., Grossman A. Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro. Brain Res. 502:1989;167-170.
42. Valentine J.D., Matta S.G., Sharp B.M. Nicotine-induced cFos expression in hypothalamic paraventricular nucleus is dependent on brainstem effects: correlation with cFos in catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius. Endocrinology. 137:1996;622-630.
43. Verbalis J.G., Stricker E.M., Robinson A.G., Hoffman G.E. Cholecystokinin activates c-Fos expression in hypothalamic oxytocin and corticotropin-releasing hormone neurons. J. Neuroendocrinol. 3:1991;205-213.
44. Wahlestedt C., Skagerberg G., Ekman R., Heilig M., Sundler F., Hakanson R. Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res. 417:1987;33-38.